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Abstract
In the present study, we have provided two sets of high spatial-resolution maps for
neuronal populations containing the immunoreactive presence of the key feeding-related peptides
hypocretin/orexin (H/O), alpha-melanocyte stimulating hormone (αMSH) and the nitric oxideproducing enzyme, neuronal nitric oxide synthase (nNOS). These were mapped across the
mediolateral and dorsoventral extents of the hypothalamus in the Swanson rat brain atlas, from
levels 23–30. The first set of these maps are of the chemoarchitectural distributions for each of
the neuronal populations mentioned, which are novel in two ways. First, they were generated
across multiple animals to serve as the basis for probability maps of the distributions of these
peptides. Second, they include fiber systems that are mapped to a standardized atlas. A second
set of maps was generated of the mesoscale-level putative interactions between H/O- or αMSH-ir
axonal fibers and nNOS-ir somata. These mesoscale-level putative interaction maps will help
shed some light on the possible interactions between these feeding control neuropeptides and a
known modulator of feeding and metabolic responses, nitric oxide. The interaction maps were
also completed for multiple animals and will be the basis of probability maps that will be
provided as a tool for further exploration of these interactions with techniques that require
targeted delivery of molecules such as optogenetics, chemogenetics, and tract-tracing studies.
These datasets will also benefit researchers who use techniques where it is difficult to survey
large areas to find targeted interactions, such as patch-clamp electrophysiology or electron
microscopy.
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Introduction

A look back to plot a course forward
“It is often the case in science that events that are considered "landmarks" have extensive
historical antecedents and emerge at a time of divided opinions, considerable debate, and
marked interest in the phenomenon.” – Sondhaus and Finger, 1988.

It is widely considered that a major event which tipped the scales in favor of the
popularization of the localization theory in the brain; that is, the idea that different parts of the
brain serve different functions, was that of the descriptions of patient “Tan” by Pierre Paul Broca
in 1861 (Broca 1861, Finger 2001, Sondhaus and Finger 1988). The historical review of aphagia
from which the above excerpt was taken, however, reminds us that the historical precedent had
been previously established, far before the time of Broca. By presenting the history leading up
this moment, Finger brings to light an interesting question; why did this specific description of
Broca’s echoing an idea presented by many before him, create a shift in perception at a time
when science had been divided on the issue for so long? Sondhaus and Finger argue that it was
due to four factors: 1. the detail of the descriptions, 2. distancing from phrenology, 3. zeitgeist or
a willingness of the scientific community to accept the ideas; and 4. the respect that Broca had
acquired. These factors, argue Sondhaus and Finger, all coalesced to make this report of patient
“Tan” the one to tip the scale. Of these factors, I would like to focus on the importance of the
first, the detail that was given to the study of patient “Tan”. Kussmaul (1878) makes note of the
reports prior to that of Broca and mentions of these that “…Bouillaud, Lallemand and Rostan, to
whom, notwithstanding, the pathology of the brain owes so much. They are content to indicate
the affected lobe with the general designation, "in front," "be-hind," "in the middle," etc., and
with an equally indefinite appreciation of the extent of the lesion. (p. 721)” This lack of detail in
the reporting of the dimension and location of lesions observed by these brain pathologists may
have delayed the widespread acceptance of localization theory. With a small refinement of the
descriptions for the localization of the lesions observed in patient “Tan” and the distinction
1

between loss of articulation of speech and not a general loss of speech, Broca had distinguished
his study from those which came before (Sonhaus and Finger 1988).
Since the descriptions of Broca, the localization theory of the brain has been scaled down
to an ever-finer resolution in its descriptions of the various regions, which we have discovered
seldom govern a single distinct function, but consistently overlap in functions by the neuronal
constituents that make them up. Even when considering the famed Broca’s area there are a
number of studies which continue to parcel out the cytoarchitectural boundaries and distinct
aspects of speech governed by this area (Anwander et al 2007, Amuntz et al 1999, Amuntz et al
2004, Heiser et al 2003, Maess et al 2001, Grodzinsky 2000).
Parceling out intermingled circuits
In the nearly 160 years since Broca initially popularized the theory of localization, which
helped to set in motion a concerted effort in neuroscience to break down the brain into its most
individual elements, neuroscience has developed elegant tools and methods to characterize each
of these individual elements. These range from well-constructed behavioral paradigms which
allow for dissociation of entangled behaviors such as those explored by McDonald and White in
1993, to the development of technology such as optogenetics and chemogenetics (Boyden et al
2005, Urban and Roth 2014) which have enabled scientists more recently to begin determining
the neural substrates of memories in the form of engrams (Hübener and Bonhoeffer 2010,
Ramirez et al 2005, Rashid et al 2016, Kim and Cho 2020). This complexity of integration of
information for storage and retrieval of information has even been extended to single synapses
and the molecular constituents which alter them (Govindarajan et al 2006). These advancements
in neuroscience have allowed for a deep and important exploration of the individual elements of
the brain. However, it would be a travesty if once we have characterized these individual
elements to their fullest extent, we found ourselves unable to build the model back up due to our
limited understanding of where each of these pieces was extracted from. Anyone who has ever
2

taken apart a complex machine can attest to the importance of knowing from where each piece
was removed in order to reassemble it. The increasing complexity that is observed when
examining brain regions which integrate inputs from different sources, encode different aspects
of that information, and store and retrieve these and form a cohesive cognitive experience;
underscore the same principle that is illustrated by Broca’s description of patient “Tan”, the
importance of recording these findings with the highest possible spatial resolution.
Understanding “The Brain”: Making datasets comparable
Cartography has been a trade that has benefited humanity since its earliest credited
recording in the continent of Asia (Bagrow 2010). Since then, a variety of methods have been
used to create accurate representations of the world we inhabit, ranging from use of the stars to
mountains rivers and man-made structures (Bagrow 2010). These representations of Earth have
been refined and how we acquire our representation have also improved over time. Representing
the Earth, however, can be done to a high degree of accuracy with relative ease with present
technology because there is only one planet Earth. This is not the case when thinking about
cartography of “the brain”. In our efforts to begin to understand “the brain” it is important to
acknowledge that there is no single brain that is able to represent all brains across species or even
within a single species. For this reason, there have been committees and institutes formed by
various organizations throughout the world to standardize mapping of the human brain in order
to render datasets acquired through different methodologies comparable to one another (Pechura
and Martin 1991, Huerta et al 1993, Mazziota et al 2001). Of all of these approaches, the most
interesting one to us here is the one adopted by the International Consortium for Brain Mapping
(ICBM) which has opted to not only standardize the mapping of data to the human brain but also
take into account the fact that every brain is different by proposing a probabilistic standardized
atlas (Mazziota et al 1995, Mazziota et al 2001). In viewing an atlas as a model that is then filled
and refined with data across multiple brains which are rendered comparable to one another by
3

the common mapping practices across the field, science allows for a model that is then predictive
of regions and trends that are more representative of a population. Doing this allows for better
targeting of therapeutics in the medical field as well as better insight into what variations are less
common and may therefore indicate some forms of pathology.
This, however, is a practice that is not as prevalent within studies of animal models which
are used to make initial discoveries toward our understanding of the nervous system, and which
form the basis for translational studies. Within the rat model, a major driving force for the
adoption of these same methods is Dr. Larry W. Swanson (Swanson 2018), and the Swanson rat
brain atlas is unique in some very important ways (Swanson 2018). These include being the first
atlas to provide computer-generated atlas templates for digital mapping of the brain, ensuring
that these atlas templates are spatially aligned in order to create a 3-D representation of the data
mapped to this atlas. Additional benefits from this atlas come from the nomenclature, which is
made up of four hierarchical tables and have in the most recent versions of the atlas included a
pan-mammalian nomenclature that will begin to facilitate the comparison of homologous
structures among all mammalian species. This atlas model has been used by various laboratories,
including by our UTEP Systems Neuroscience Laboratory at The University of Texas at El Paso
(e.g., Khan 2013, Swanson et al 2005, Hahn 2010, Hahn and Swanson 2012, Santarelli et al
2018, Khan et al 2007, Watts and Sanchez-Watts 2007, etc.).
A true understanding of “the brain” is well underway and much like the landmark
findings of Broca, it is this author’s opinion that the deciding factor that will bring about the next
big breakthroughs in neuroscience will be facilitated by the extra detail provided by standardized
mapping.
The hypothalamus: a model for a probabilistic atlas
The hypothalamus is a prime example of an integrative center containing neuronal
populations involved in the control or regulation of various functions essential for survival
4

including feeding, wakefulness, fluid balance, thermoregulation, sexual behaviors, and
reproduction as well as the stress response and aggression (Saper and Lowell 2014, Simerly
2015). Its location at the base of the brain makes it an ideal structure for the integration of
peripheral and central signals of internal state, which allow it to sense and respond to any
situation that is happening in the body (Saper and Lowell 2014, Simerly 2015, Sawchenko
1998). Because of the presence of the third ventricle in the hypothalamus, there are several
different neuronal populations that are specialized to sense - and alter firing patterns in response
to - levels of circulating, peripheral signals which communicate information about the internal
states of different organs and metabolic processes. These signals include glucose, peptide
hormones, amino acids, lipids and, in some regions, even temperature (Routh et al 2014, Saper
and Lowell 2014, Schwartz et al 2000, Siemens and Kamm 2018). These peripheral signals are
also complimented by ascending pathways from visceral inputs originating from brainstem
regions as well as direct innervation from vagal afferents (Yu 2011; Saper and Lowell 2014).
This framework of inputs from circulating signals and direct neuronal connections allows the
hypothalamus to integrate and contextualize the physiological responses of the body in order to
produce an appropriate response through humoral or direct efferent connections (Saper and
Lowell 2014, Schwartz et al 2000, Routh et al 2014, Fioramonti 2010, Simerly 2015). The
numerous functions that are integrated within the hypothalamus make for a prime example of an
area where multiple circuits activated under different contexts need to be characterized with
high-spatial resolution.
Neural substrates of feeding
At the center of hypothalamic feeding circuitry, we find at least four major neuropeptide
neurotransmitters which have been explored in depth by various investigators for decades now.
These include pro-opiomelanocortin (POMC) (more specifically, alpha-melanocyte-stimulating
hormone, or αMSH), agouti-related peptide (AgRP), hypocretin/orexin (H/O) and melanin5

concentrating hormone (MCH); which each exert effects not only on feeding but influence
several other physiological functions (Saper and Lowel 2014, Simerly 2015, Yu and Kim 2012,
Sawchenko 1998). These four major neuropeptides are often heuristically divided between two
functional groups of neuronal populations within the context of feeding control and metabolic
regulation: first-order and second-order neurons. αMSH- and AgRP-expressing neurons are
considered to be first-order neurons because of the roles they play in the integration of peripheral
signals from signaling hormones which communicate the energy status of the body, such as
insulin, ghrelin, and leptin, among others (Traebert et al 2002). These neurons are believed to
communicate to laterally-located second-order neurons in the hypothalamus such as MCH- and
H/O-expressing neurons which, in turn, project to downstream targets to coordinate different
ingestive behaviors and metabolic effects (Borgland 2006, Sheng et al 2014, Teegala et al 2018,
Vittoz et al 2006, Yoon 2013, Elias 2008). However, it must be acknowledged that neuronal
populations at each hypothalamic region respond to these peripheral signals, and also receive
signals from other regions that respond to these peripheral signals, bringing a larger complexity
to this understanding of primary and secondary neurons (Hsu et al 2015, Goforth et al 2014,
Olszewski et al 2003). Anatomical evidence for these relationships can be observed, at least for
αMSH, in the findings of a seminal paper by Elias et al in 1998, which reported the putative
interactions of αMSH-ir axonal fibers with H/O- or MCH-ir somata. The precise distributions of
these anatomical interactions, however, were not mapped systematically, and although
distributions of MCH and H/O-ir somata were reported, these were not placed in relation to a
standardized atlas. Each of these neuropeptides is essential to feeding control circuitry, but it
must be acknowledged that these are not the only neurotransmitters to be considered in
discussing ingestive behaviors and metabolic regulation. For example, the gaseous molecule
nitric oxide (NO), has been reported to modulate the effects of various feeding control
neuropeptides, including H/O, neuropeptide Y (NPY), ghrelin, and cholecystokinin (CCK)
(Morley et al 2011, Farr et al 2005, Gaskin et al 2003). The widespread modulatory influence
that NO might have on feeding control circuits has not yet been characterized anatomically. It
6

would stand to reason that a neurotransmitter that could exert profound effects on feeding control
circuits would be in some way influenced by the neuropeptides within those circuits. For this
reason, we will be exploring the possibility that NO-producing neurons receive putative
appositions from αMSH- or H/O-ir axonal fibers throughout various sub-regions of the
hypothalamus. H/O and αMSH were selected for study because of their established orexigenic
and

anorexigenic

effects,

respectively.

For

these

neuronal

populations,

we

immunocytochemically stained for hypocretin 1/orexin A, and αMSH. In the case of NO, which
cannot be directly stained using antibodies (as it is a gaseous neurotransmitter), we used
antibodies directed against the enzyme responsible for its production within the nervous system,
neuronal nitric oxide synthase (nNOS).
The melanocortin system
Alpha melanocyte-stimulating hormone (αMSH) belongs to a family of peptides known as the
melanocortins, which are derived from the common precursor protein, pro-opiomelanocortin,
when proteolytically processed by protein convertases (Chretien and Mbikay 2016). Other
peptide hormones in this family include adrenocorticotropic hormone (ACTH), β-lipotropin (βLPH), γ-lipotropin (γ-LPH), corticotropin-like intermediate peptide (CLIP), β-melanocyte
stimulating hormone (βMSH), and γ-melanocyte stimulating hormone (γMSH) (Chretien and
Mbikay 2016, Cone 2005). The discovery and initial description of the amino acid sequence of
αMSH came in 1955 and 1957, respectively, out of American dermatologist Dr. Aaron B.
Lerner’s laboratory at the Yale University School of Medicine (Lerner and Lee 1955, Harris and
Lerner 1957). Initial descriptions of the effects of αMSH in the nervous system included reports
of its control of sexual behaviors and influence on the production of peptide messengers
controlling metabolic processes (Knudtzon 1984, Raible and Gorzalka 1986, Hughes et al 1988).
Later, this peptide was also implicated in control of anxiety and immunity (Star et al 1995,
Kokare et al 2010). However, the main focus of research for αMSH has been its role as a
7

neuropeptide controlling feeding behavior and regulating metabolism (Cone 2005). The presence
of αMSH-immunoreactive (-ir) somata have been reported within the arcuate hypothalamic
nucleus (ARH) while αMSH-ir fibers have been found in the amygdala, nucleus of the solitary
tract, hypothalamus and central gray, among other regions (Jacobowitz and O’Donohue 1978,
O’Donohue et al 1979, Rao et al 1987). These distributions were very elegantly mapped by
Jacobowitz and O’Donohue using stereotaxic coordinates. Here, we have updated these maps
using more modern techniques and have also mapped them with reference to the Swanson rat
brain atlas.
Hypocretin/Orexin
Hypocretin, also referred to as orexin (H/O), is a hypothalamic neuropeptide that was
independently discovered and initially described by two groups within a month of each other
(Sakurai et al 1998, de Lecea et al 1998). These initial descriptions of H/O found that this
peptide had strong amino acid homology with the gut peptide, secretin, and that the
intracerebroventricular administration of H/O led to an increase in feeding in sated rats. This
feeding effect was found to be a hedonic one mediated, in part, by projections from these H/Oexpressing neurons to ventral tegmental area (VTA) dopaminergic neurons (Borgland 2006,
Sheng et al 2014, Teegala et al 2018). Studies have also demonstrated that there is a diurnal
difference in the activation of H/O-expressing neurons in rats (e.g., Estabrook et al 2001). Later,
through the use of optogenetics, it was reported that H/O also plays a role in mediating
wakefulness in mice (Adamantidis et al 2007). Original descriptions of the distributions for H/Oexpressing neurons in mice came from the original studies by the Sakurai and de Lecea groups
which were later confirmed and expanded upon for the rat (Swanson et al 2005, Hahn 2010).
Within the rat, the distributions of H/O-ir somata are found to be in various lateral hypothalamic
area (LHA) subdivisions, as well as the dorsomedial hypothalamic nucleus (DMH). This is not
the case with H/O-ir axonal fibers, as these have been found to span the entire brain, having
8

some representation in every sub-region of the hypothalamus and a strong presence in other areas
such as the locus coeruleus, raphe nuclei, pontine reticular formation, and as previously
mentioned, the VTA.
Nitric oxide and neuronal nitric oxide synthase
The discovery of nitric oxide (NO) as a signaling molecule within the cardiovascular system
earned Robert F. Furchgott, Louis J. Ignarro and Ferid Murad the Nobel Prize in Physiology or
Medicine in 1998. This gaseous neurotransmitter has been observed to have varying effects on
synaptic transmission, depending of what type of synapse and where in the nervous system it is
located (Garthwaite 2008). Everything that is known about the way that NO affects the synapse,
however, comes from electrophysiological studies, due to the fact the there is no way of directly
visualizing the presence of NO post mortem due to its gaseous nature. Thus, a proxy must be
used to be able to analyze the distributions of where NO signaling may be taking place
throughout the brain. Currently, neuronal nitric oxide synthase (nNOS) is the most widely used
biomarker proxy for NO, as it is the rate-limiting enzyme for the production of NO from the
amino acid, L-arginine (Knowels et al 1994). Distributions of this enzyme were initially mapped
throughout the brain of the rat with the purpose of identifying the neuronal populations which
were responsible for the NADPH diaphorase histochemical stain, which had been used for
decades as a counterstain for the visualization of brain regions (Vincent and Kimura 1992).
Later, there were more detailed descriptions of the distributions for nNOS-expressing cells
within the hypothalamus, with an emphasis on the co-localization of the enzyme with various
neuropeptides including enkephalin, cholecystokinin, galanin, oxytocin, substance P,
corticotropin-releasing hormone, and somatostatin, among many others involved in reproductive
regulation (Yamada et al 1996, Chachlaki et al 2017, de Tassigny et al 2007, Bouret et al 2000).
The mapping of these co-localized elements by Yamada and colleagues (1996) is of particular
interest, as nNOS immunoreactivity was found co-localized with all of these different
9

neuropeptides within many of the same regions where we observed signal in the present study, as
will be described later. The conclusion that this group drew from their study is that nNOS is
likely involved in a variety of different neuroendocrine and autonomic functions. It is now
known that one of the many roles that nNOS plays within the hypothalamus is as a modulator or
mediator of the effects of various feeding-related peptides such as ghrelin and H/O (Farr et al
2005, Morley and Flood 1992, Morley et al 2011, Gaskin et al 2003).
Aims
The overarching goals of this study are to 1) provide a proof-of-concept for the benefits
of mapping to a common spatial framework, which in this case is the Swanson rat brain atlas;
and 2) provide datasets that will serve as the basis for development of probabilistic maps for
chemoarchitecture and mesoscale putative interactions for key neuropeptides involved in feeding
control and metabolic regulation. In order to realize these goals, we will be using the
hypothalamus as a model brain structure, owing to its integration of various sets of homeostatic
and behavioral functions as well as the extensive characterization of different neuropeptide and
connectional datasets which have been mapped to the Swanson rat brain atlas. For this study, we
will focus on three peptide constituents of feeding circuitry in the hypothalamus, two of which
are at important for the integration of feeding control signals and one which is a noted modifier
of this system. These peptides are alpha-melanocyte-stimulating hormone (αMSH), hypocretin
/orexin (H/O) and neuronal nitric oxide synthase (nNOS). In the first aim, we generated detailed
maps using rigorous cytoarchitectonic analysis for the chemoarchitectural distributions of H/O,
nNOS and αMSH through the full dorsoventral and mediolateral extents of the hypothalamus
using the Swanson atlas (Swanson, 2018), at levels 23–30. For the second aim, we have
generated detailed mapping of the distributions of nNOS-ir somata receiving putative appositions
from αMSH- or H/O-ir fibers throughout Swanson atlas levels 23–30 containing the
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hypothalamus. Using these two aims, we plan to explore our hypothesis that αMSH- and/or H/Oir fibers make extensive contacts with nNOS-ir positive somata throughout the hypothalamus.
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AIM 1: Atlas based mapping of novel co-spatial distributions for αMSH, H/O
and nNOS in the adult male rat
Objective
In this aim, we have generated detailed maps using rigorous cytoarchitectonic analysis for the
chemoarchitectural distributions of H/O, nNOS and αMSH through the full dorsoventral and
mediolateral extent of the hypothalamus for Swanson atlas (Swanson, 2018) levels 23–30. A
number of studies have examined the chemoarchitectural distributions for each of the neuronal
populations expressing key peptides that were mapped in this study; however, most of these
studies were mapped to atlases other than Swanson 2018, or were not mapped to an atlas at all
with the exception of H/O. Here we have used various tissue series from four different animals to
co-label neurons expressing αMSH and nNOS, or αMSH and H/O. Three tissue series were
mapped for each immunohistochemical staining combination. These staining combinations were
used to compare the presence of these neuropeptides (αMSH and H/O) and enzyme (nNOS)
across different animal cases, allowing for semi-quantitative comparisons across regions to
determine regions of lower and higher variability in their expression patterns. These combined
immunoperoxidase staining protocols were also used to facilitate the analysis of putative
appositions across different cases for determining regions where H/O- or αMSH-ir fibers contact
populations of nNOS-ir somata in the hypothalamus represented between Swanson atlas levels
23–30; this work will be discussed in Aim 2.
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Methods
Animals
For this study, we used adult male Sprague Dawley rats as our animal model, which has been the
model used in previous neuroanatomical studies involving some of the peptides observed in this
study. Every animal was housed in a temperature and humidity-controlled vivarium in a 12 h:12
h light:dark photoperiod (lights on at 7:00 A.M.). Animals were given access to food and water
ad libitum. All experiments were performed according to the NIH Guidelines for the Care and
Use of Laboratory Animals, and all protocols were approved by the Institutional Animal Care
and Use Committee of the University of Texas at El Paso. Four animals were used in this study
for all immunoperoxidase assays performed (n = 4).
Transcardial perfusion and tissue sectioning
Animal weights for these animals ranged from 302–375 g around the time of perfusion. All
perfusions took place three to five hours after the initiation of the light cycle. Animals were
deeply anesthetized under 4% isoflurane (Vedco, St. Joseph, MO) in an induction chamber
(Scienceware, South Wayne, WI) for 40 s to 1 m prior to transcardial perfusion with ice-cold
0.9% saline. This was followed by perfusion with 4% paraformaldehyde (PFA) dissolved in 0.05
M phosphate-buffered saline (PBS) (pH 7.4 at room temperature). Following fixation, brains
were carefully removed and placed in additional fixative solution (buffered 4% PFA), then stored
in 0.05 M phosphate-buffered saline (PBS) with 20% sucrose for 24 hours at 4°C. The brains
were then rapidly frozen in supercooled hexanes for long-term storage at –80°C. Prior to tissue
sectioning, brains were separated into hindbrain and forebrain tissue segments to section only
those regions of tissue required for experiments. The remaining blocked tissue was frozen and
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stored again at –80°C. Tissue blocks were sectioned in the coronal plane at 30 μm-thickness
using a Reichert sliding microtome (Reichert, Austria, Nr. 15 156) fitted with a modified
freezing-stage (Brain Research Laboratories, Newton, MA; Cat #3488-RJ). All tissue sections
were collected as six 1-in-6 series and placed into 24-well plates filled with cryoprotectant
solution (30% ethylene glycol, 20% glycerol in 0.05 M sodium phosphate buffer) for storage at –
20°C until further processing. In most cases, the third tissue series collected was reserved for
preparing a cytoarchitectural reference series using Nissl staining, while the remaining tissue
series were reserved for immunohistochemical analyses.
Histochemistry
Nissl staining
Sections were removed from cryoprotectant solution and washed five times for a period of five
minutes (5×5) in netted well trays with 0.05 M Tris Buffered Saline (TBS) solution (pH 7.4 at
room temperature) prior to mounting them onto gelatin-coated slides (Simmons and Swanson,
1993). Sections were allowed to air-dry overnight at room temperature prior to being dehydrated
in ascending ethanol concentrations (50%, 70%, 95%, and 3×100% for 3 min each) and
delipidized in two sequential xylene baths for 12 min each. Sequential rehydration of the sections
was performed in descending ethanol concentrations (100%, 95%, 70% and 50% for 3 min
each). Sections were then rinsed with distilled water for 3 min prior to staining with 0.25% (w/v)
thionine for approximately 1 min and 30 sec. The tissue sections were then quickly submerged in
0.4% glacial acetic acid to remove excess thionine and to differentiate cellular staining from
background, and then rinsed with distilled water. Stained tissue sections were again sequentially
taken through progressively concentrated ethanol solutions (50%, 70%, 95%, and 3 ×100% for 3
min each). Sections were cleared with xylenes for 24 min (two sequential 12 min baths) and
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finally coverslipped using dibutylphthalate polystyrene xylene (DPX) mounting medium (catalog
#06522; Sigma-Aldrich, St. Louis, MO).
Immunoperoxidase Histochemistry (IHC)
Immunoperoxidase staining was performed on a series of tissue sections adjacent to that of the
Nissl-stained tissue series (n = 4). Sections were transferred to a netted washing tray filled with
0.05 M TBS (25°C, pH 7.4) five times for periods of five minutes each (5×5) to remove
cryoprotectant. The netted tray containing the tissue sections was then filled with a solution of
TBS containing 0.014% phenylhydrazine and allowed to mix with sections for 20 min to
suppress excess endogenous peroxidase activity. Sections were again washed 5×5 with TBS and
placed in blocking solution (2% (v/v) normal donkey serum; EMD Millipore, Burlington, MA;
Catalog #S30-100ML; Lot #2510142; 0.1% Triton X-100; Sigma-Aldrich; Catalog #T8352500ML, Lot #MKBH4307V; in TBS) to incubate for one hour. Sections were then transferred
into a sterile 24-well plate containing primary antibody solution for 48–72 hours at 4°C (details
in Table 1). For the following procedure, biotin-conjugated secondary antibodies were separated
into two staining rounds to allow for independent staining with 3, 3´-diaminobenzidine (DAB)
(which produces a brown-colored precipitate) (Sigma-Aldrich) and ammonium nickel (II) DAB
(which produces a black-colored precipitate). Sections were then washed 5×5 and transferred to
their respective secondary antibody solutions containing biotinylated donkey-derived antibodies
to incubate for 5 hours. Tissue sections were then placed in 5×5 washes in TBS and subsequently
placed into avidin-biotin-horseradish peroxidase complex-containing solution (VECTASTAIN
Elite ABC-peroxidase kit, Vector Laboratories, Catalog #PK-6100, RRID:AB_2336819; 0.45%
v/v reagents A and B; 0.1% Triton X-100 in 0.05 M TBS). Sections were then washed 5×5 in
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TBS and placed in their respective immunoperoxidase solutions containing 0.1% w/v ammonium
nickel (II) sulfate, 0.05% 3, 3´ diaminobenzidine, 0.005% (v/v) H2O2 and 0.05 M TBS and kept
in constant observation until an adequate colorimetric signal was developed. Special care was
taken to ensure that background staining did not exceed a point that would make visualization of
signal difficult. Steps for secondary staining were then repeated in the same way as before for the
second antigen, except the DAB solution did not include ammonium nickel (II) (0.05% w/v
DAB, 0.015% v/v H2O2 dissolved in 0.05 M TBS). A final 5×5 wash in TBS was performed, and
then sections were mounted onto gelatin-coated slides and allowed to dry overnight at room
temperature. Slides with mounted sections were then dehydrated in ascending concentrations of
ethanol (50%, 70%, 95%, 100% for 3 minutes each), followed by 24 minutes (two sequential 12
min baths) in mixed xylenes to delipidize the tissue. Slides were immediately coverslipped using
DPX (Catalog #06522; Sigma-Aldrich) mounting medium.
Imaging and Image Alignment
Bright-field photomicrography
Photomicrographs were obtained with the use of an Olympus BX63 light microscope with a
DP74 color camera attached and equipped with an X-Y-Z motorized stage (Olympus
Corporation, Center Valley, PA) driven by cellSense™ Dimension software (Version 2.3),
which was used to photograph and stitch Nissl- and DAB-stained tissue sections. Hemi-sections
corresponding to the same side of the brain for both sets of tissues were photographed at ×10
magnification (N.A., 0.3) for alignment purposes. Another set of photographs of DAB-stained
tissues was obtained at ×100 magnification (N.A., 1.4) to visualize individual putative
appositions.
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Image Alignment and Demarcation
Adobe Illustrator (AI; Version CC 18.0.0; Adobe) was used as the platform through which all
images and data processing took place for the generation of all steps of the mapping process.
High-resolution photomicrographs of bright-field Nissl-stained sections were loaded into AI and
resized to 25% of their original size. The size reduction was carried out to ensure that the scaling
of parcellations and data placed in layers over these images will also be scaled and aligned
appropriately when transferring the data to atlas templates. A separate layer was created to
contain all lines used to delineate cytoarchitectural boundaries Figure 1. The criteria for
delineation of cytoarchitectural boundaries in this study follow that of Swanson 2004 and draw
upon a large body of peer-reviewed literature. Briefly, these criteria included directionality,
staining intensity, packing density, morphology, and distribution of somata as revealed by Nisslstained sections (Simmons and Swanson 1993). Once boundary delineations were completed,
photomicrographs of the adjacent immunoperoxidase-stained sections were imported into AI as
separate data layers and aligned with photomicrographs of the Nissl-stained tissue section using
fiducial landmarks such as white matter tracts and vasculature in the tissue sections to bring them
into register, as described previously (Zséli et al., 2016). When needed, images of Nissl-stained
tissues were adjusted for brightness or contrast to better visualize cytoarchitectural features.
Other than rotation and scaling adjustments for alignment purposes, no other alterations were
made to photomicrographs of the immunoperoxidase- or Nissl-stained tissue sections. This
ensured that there was a proper registration between the Nissl-stained sections and
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Figure 1. The mapping process. (A, B): A photomicrograph of a Nissl-stained tissue section representing atlas
level 30 provides a visual representation of how cytoarchitectural delineation (parcellation) is carried out. The
bottom left scale bar denotes 100 µm. (C): A photomicrograph of a DAB-stained tissue section being overlaid and
aligned onto a photomicrograph of Nissl-stained tissue section by dropping the opacity of the photograph and
using fiducial landmarks to align the two images. (D): Once photomicrographs have been aligned, parcellations are
aligned with the DAB photomicrograph. (E, F): A separate data layer is then created over the DAB image where
ellipses and hand-drawn lines are placed to demarcate where somata and fibers, respectively, are located in the
tissue. This process leads to the final product shown in (E), where all data are placed on the atlas map. Please
consult the Appendix for a list of terms corresponding to the anatomical abbreviations used in this figure.
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immunoperoxidase-stained sections, to allow for the correct overlaying of cytoarchitectural
boundaries onto photomicrographs of the immunoperoxidase-stained sections. Additional data
layer overlays were created in AI in which immunoreactive cell somata and fibers were marked
using ellipses and hand-drawn lines, respectively. For this peptide-expressing cell/fiber
demarcation step, special attention was paid to represent all spatial distribution trends for fibers
and to provide the best one-to-one representation of cell bodies that could be performed from the
photomicrographs used. Additional refinement of cell somata denotation was performed for
immunoperoxidase histochemistry of nNOS-ir somata when analyzing tissue sections under
×100 magnification to increase accuracy of cell counts in later steps.
Translation of data to atlas templates
Data processed after the image alignment and demarcation step were then transferred to Swanson
rat brain atlas templates (Brain Maps 4.0; Swanson, 2018) according to the following sequence
of steps. In AI, using the Lasso Tool, cell body and fiber demarcations from each hypothalamic
sub-region were selected, copied and pasted onto corresponding atlas templates over the
appropriate regions. These data were then transformed (scaling, rotation, distortion and
individual translocation of fibers and somata) with every sub-region transferred treated as a unit,
to ensure that visual trends and relationships between data were preserved and remained
consistent with those observed in the tissue sections (Zséli et al., 2016). Special care was taken to
examine distributions of cells and fibers in the context of orientation (fiber direction) and their
positional relationships to the experimental tissue’s regional boundaries. Adjustments to
accommodate regional distortions between the experimental tissue and the atlas representation
were approximated by eye and applied to the data.
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Semi-quantitative analysis of cell counts
The total counts for cells containing putative appositions for each neuropeptide were acquired by
sub-region using the Lasso and Document Information tools in AI to count ellipses that had been
used to mark the presence of each cell. Similarly, cell counts for each peptide were acquired and
used to provide percentages of cells containing putative appositions with respect to the total
number of cells by region. The analysis of somata in this study is semi-quantitative, and
therefore, provides an assessment of the number of cells observed rather than the proportion of
observed cells to those populating the full representation of each region. This method did not
employ the use of cell counting software in combination with a pan-neuronal label and so the
semi-quantitative measures must be interpreted with this understanding; however, our counts
underwent rigorous refinement through our use of a ×100 magnification objective lens to analyze
the presence of each nNOS-ir soma, as described in the methods of Aim 2.
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Results
The spatial distributions of the data plotted in the maps generated in this study were determined
by superimposing the drawn boundaries of hypothalamic sub-regions determined by
cytoarchitectural criteria, as revealed by adjacent Nissl-stained tissue sections. The
cytoarchitectural criteria used in this study are based on those used by Swanson (2004), which
draw upon a wide variety of studies for each of the hypothalamic sub-regions presented. In
summary, these are the morphology, staining intensity, orientation, packing density and
distribution as revealed by Nissl-stained sections (Simmons and Swanson 1993). The scope of
the current study includes atlas templates (levels 23–30) which, cover two of the four major
rostrocaudal divisions of the hypothalamus (anterior and tuberal). For each of these levels, the
entire

mediolateral

and

dorsoventral

extents

of

the

hypothalamus

were

analyzed.

Cytoarchitectural boundaries of tissue sections were used to identify them as corresponding to
one of the atlas levels observed in this study (plane of section analysis), which then allowed for
the transfer of data from immunohistochemically-stained sections to atlas templates. These same
cytoarchitectural boundaries established with the use of Nissl-stained tissue sections are overlaid
onto the immunohistochemically-stained sections using Adobe Illustrator software to organize
them into layers. Layering in Adobe Illustrator also allowed for the migration of data from tissue
sections to approximate locations of all mapped cell bodies and fibers onto atlas templates in this
study.
Distribution of α-MSH-ir fibers and somata throughout the hypothalamus
Observations for trends and distributions of αMSH-ir fibers and somata were made based on
staining performed in tissue sections from four different animals. αMSH-ir somata present as

21

Figure 2. Representative maps for levels 23–30 of αMSH-ir somata and fibers. Please consult the
Appendix for a list of terms corresponding to the anatomical abbreviations shown in this figure.
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grainy clusters with undefined edges, with some somata staining in a very light, almost
indistinguishable intensity. This staining profile remains constant across all cases examined. The
distribution of αMSH-ir somata is restricted to the ARH and immediately adjacent regions such
as the TUsv, beginning at level 26 where the ARH first emerges and throughout the rest of the
surveyed levels for most cases. However, the case represented in the maps presented in Figure 2
does not have any αMSH-ir somata at level 28 which is an exception and not the usual case. Due
to the nature of the staining and consistently restricted presence of these αMSH-ir somata, we
did not perform cell counts for these cells. These distributions are consistent with various
previous reports (Guy et al 1982, Kiss et al 1984, O’Donohue et al 1980).
The αMSH-ir fibers in this study show a varicose innervation which, much like the staining of
somata, has a broken-up appearance (Figure 6), making it difficult to follow them through a long
distance and which may influence some of the mapping we performed for these fibers Figure 6.
This staining profile is very typical of αMSH and has been described in previous studies
(Jacobowitz and O’Donohue 1978, O’Donohue et al 1979). These αMSH-ir fibers are more
sparsely distributed in lateral structures; however, there is at least a small representation of these
fibers in each hypothalamic sub-region throughout the rostrocaudal extent of the analyzed levels.
In the rostral portion of the hypothalamus, the cytoarchitectural boundaries of the SCH can be
traced out by a clear absence of αMSH-ir fibers, which appear to avoid this region. Noticeably,
when examining the DMH from levels 28–30 there is a robust and consistent presence of αMSHir fibers across cases, that appears to exclude the DMHp, almost making a very clean
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Figure 3. Different staining profiles of nNOS-ir somata in different hypothalamic regions. (A): Photomicrograph
demonstrating the staining profiles of nNOS-ir somata in the LHAav, which is noticeably low in background
staining with clear, well-defined somata (denoted by arrowheads). The photomicrograph in (C) demonstrates a
completely different staining profile from that shown in A; in this case, for nNOS-ir somata within the VMHvl,
where somata are obscured by the presence of high background signal (denoted by arrowheads). (B):
Photomicrograph showing the distinct shift in nNOS neuropil staining between the VMHc and ARH (denoted by
arrowheads). The scale bar represents 20 µm and applies to all panels.

separation between DMHv and DMHp (Figure 2, level 30). Along with the DMH, αMSH-ir
fibers can be found throughout the rostrocaudal extent of the PVH, but with a noticeable absence
in PVHpmm and PVHlp across several brains. There are also some medial zone regions that
appear noticeably to have lower densities of αMSH-ir fibers. These include the VMHdm and
VMHc as well as the VMHa which was virtually devoid of any αMSH-ir fibers. Similarly, more
rostral parts of the AHN have lower densities of αMSH-ir fibers when compared to surrounding
regions. In summary, the highest concentration of fibers centers around the medial and
perifornical zones, with structures such as the PVa, PVi, PVHap, PVHpv, PVHmpd, PVHf,
DMHa, and DMHv; having the most robust presence of these αMSH-ir fibers.
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Figure 4. Example areas for dense regions of nNOS-ir somata. (A, C and E): Nissl-stained sections, from an
adjacent series to that used for the DAB-stained sections, with cytoarchitectural boundaries delineating regions of
interest for dense regions of nNOS-ir somata. (B): Tissue section DAB-stained for H/O (black) and nNOS
(brown) which showcases the presence of a dense population of nNOS-ir somata within the principal part of the
supraoptic nucleus (SOp) outlined with overlaid parcellations at atlas level 25, which is a consistent feature of this
hypothalamic region. (D): Tissue section stained for αMSH (black) and nNOS (brown) using DAB and has
overlying parcellations of the hypothalamic paraventricular nucleus (PVH) for atlas level 26 and showcases the
presence of dense nNOS-ir somata populations in PVHmpd and PVHpml, which is a common feature observed
for this hypothalamic region. (F): A DAB-stained section for H/O (black) and nNOS (brown) which has
overlying parcellations of the PVHf to showcase the presence of a dense population of nNOS-ir somata, which is
a common feature of this hypothalamic sub-region. Each scale bar represents 100 µm. Please consult the
Appendix for a list of terms corresponding to the anatomical abbreviations shown in this figure.
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Distribution of nNOS-ir fibers and somata throughout the hypothalamus
Distributions of nNOS-ir fibers and somata are based on staining performed in tissue sections
from four animals. The distributions of nNOS-ir somata were found throughout most of the
hypothalamus to varying degrees, showing different staining profiles and notable regions of clear
absence. Some areas of note when examining the differences in staining for nNOS-ir somata are
the entirety of the VMH and some of the more laterally located LHA sub-regions, such as the
LHAav (Figure 3). The VMHvl was observed to display a high degree of “background staining”,
which can be designated as neuropil that gives a cloudy appearance to nNOS-ir somata contained
in this region. However, this neuropil is observed throughout the rostrocaudal extent of the VMH
with varying degrees across its different sub-regions. In contrast, more laterally located regions,
such as the LHAav, show very clearly defined nNOS-ir somata with no neuropil staining,
accentuating the morphology of these neurons. Immunohistochemical staining of nNOS-ir
somata and neuropil can almost be used as a counterstain in some regions. This is due to the
presence and absence of the staining for this enzyme that very closely follows the
cytoarchitectural boundaries that are derived using adjacent Nissl-stained tissue sections (Figure
4). Some extrahypothalamic regions, such as medial amygdalar nucleus anterodorsal part
(MEAad), AAA (among other amygdala sub-regions), and the BST, also merit mention based on
these same observations. When examining the average percentages of nNOS-ir somata by level,
the atlas levels with the greatest numbers of nNOS-ir somata are levels 25, 29 and 30, with
almost identical averages of 15.4% ± 0.57% (95% CI 3.22), 15.4% ± 1.1 (95% CI 4.37) and
15.7% ± 0.66% (95% CI 2.59), respectively. In contrast, the two atlas levels with the lowest
percentages of nNOS-ir somata were levels 26 and 27, with an average of 9.3% ± 0.6% (95% CI
2.39) and 7.4% ± 0.45% (95% CI 1.28), respectively. For reference, there was an average of
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4,948 nNOS-ir somata per case. The sub-region which consistently had the greatest number of
nNOS-ir somata across all cases was the LHAav, with an average of 632 ± 29 somata (95% CI
114) per case, making up an average of 13% ± 0.39% (95% CI 1.51) of all somata per case
within the levels analyzed. The hypothalamic sub-region containing the greatest number of
nNOS-ir somata after the LHAav is the LHAai, which contains an average of 370 ± 11 (95% CI
45) somata per case, which is just over half that of the LHAav, at 7.7% ± 0.21% (95% CI 0.81).
A more general observation of the distributions for nNOS-ir somata is that there appears to be, at
least to some degree, a correlation between regions which contain immunoreactive neurons and
those with a magnocellular morphology. This is evident from the consistently robust presence of
nNOS-ir somata in regions such as the PVHpml, PVHpmm, as well as the SOp and SOr, both of
which display the highest density of nNOS-ir magnocellular somata, with an average of 257 ± 24
somata (95% CI 95) and 34 ± 3.8 (95% CI 15) somata per case, respectively (Figure 5). The
presence of nNOS-ir somata, however, is not restricted to magnocellular somata, as there are also
somata with several different morphologies which are nNOS-ir. Other hypothalamic sub-regions
which contain a consistent presence of nNOS-ir somata are the DMHv, DMHp and DMHa, with
the majority of these neurons concentrated in the DHMv. At the more rostral levels analyzed,
there is also a greater consistency of somata in hypothalamic regions across the dorsal and lateral
extents of periventricular, medial and lateral zones, including in the PVHap, PVHpv, PVHmpv,
PVHpmm, PVHmpd, PVHdp. Also, there is the distinct presence of nNOS-ir somata in the PVHf
at level 27, a pattern which follows the cytoarchitectural boundaries of this region closely.
Visible nNOS-ir fibers normally do not extend far past the somata of these cells and therefore the
distributions of nNOS-ir fibers therefore coincides with all of the cell body trends mentioned
above.
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Figure 5. Representative maps for levels 23–30 of nNOS-ir somata and fibers. Please consult the
Appendix for a list of terms corresponding to the anatomical abbreviations shown in this figure.
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Interestingly, however, more lateral areas which had less neuropil staining, and therefore more
visible fibers, demonstrated that these nNOS-ir somata contain fibers which seemingly project
preferentially in a dorsoventral axis. The directionality of these fibers, however, was not
quantified in our study.
Distribution of H/O-ir fibers and somata throughout the hypothalamus
Much like αMSH-ir fibers have representation to some degree in all hypothalamic sub-regions
sampled in this study, H/O-ir fibers were consistently present in medial zone sub-regions
throughout the rostrocaudal extent of the hypothalamus. However, there is a notable decrease in
the presence of H/O-ir fibers in more ventral sub-regions at Figure 8, levels 29 and 30. More
rostral levels show a distinct decrease in H/O-ir fiber density in the lateral areas of the
hypothalamus, such as the LHAav, LHAai and LHAad. Most H/O-ir fibers for levels 23–26 are
located in more medial and periventricular zones of the hypothalamus, such as in the sub-regions
of the AHN. Specifically, the AHNc, AHNa and AHNp displayed a consistent density of H/O-ir
fibers which persists throughout all levels. Additional medial sub-regions of the rostral
hypothalamus that show a consistent presence of H/O-ir fiber densities include the AHA, MPO,
RCH, SBPV and LHAjvv; with the LHAjvv, however, displaying a decrease in density of H/O-ir
fibers at more caudal levels. VMH sub-regions also display variable H/O-ir fiber densities across
rostrocaudal levels. The VMHa displayed very little H/O-ir, yet it is still present, which is also
the case with the VMHvl. In contrast, the VMHdm and VMHc have a very high density of H/Oir fibers at levels 27 and 28 which is expected, as suggested by functional studies (Shiraishi et al
2000; Shiuchi et al 2009). This density of H/O-ir fibers then markedly decreases at the most
caudal levels 29 and 30. Another region with variable densities of H/O-ir fibers throughout the
extent of the levels where it is present is the PVH. The PVHap and PVHpv at level 23 and 24
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display a moderate amount of H/O-ir fibers which is consistent across cases. This trend changes
when examining level 25, as there are few fibers in the PVHdp, PVHmpd and PVHpv and a very
noticeable lack of fibers in the PVHpmm. At level 26, this once again changes, with the PVHdp
and PVHmpv having a higher density of H/O-ir fibers and PVHpv, PVHmpd and PVHpml again
having moderate densities of fibers. When examining PVH at level 27, there is a large increase in
the density of fibers throughout all its sub-regions, matching the overall increase in density of
fibers in the entire hypothalamus at this level. Beggining at level 28, the DMHa has a high
density of H/O-ir fibers which continues through the rest of the levels analyzed. The DMHp and
DMHv, however, do not have the same density of fibers, even though they do have some
representation of fibers at every level where they are present. Another region with a consistent
presence of H/O-ir fibers, from its emergence through the rest of the levels sampled is the ARH.
As with the VMH these observations were expected, since H/O has been reported in the region in
functional studies (Burdakov et al. 2003, Kotz et al. 2006, Rauch et al 2000).
H/O-ir somata are not present at the most rostral levels and do not become present until level 26,
which is consistent with previous studies (Swanson et al 2005, Hahn 2010). However, in this set
of data, the highest densities of H/O-ir somata are observed at levels 28 and 29, with an average
of 123 ± 18 somata (95% CI 62) and 171 ± 3.5 somata (95% CI 12), respectively; meaning that
these two levels account for 29% ± 3.5% (95% CI 12) and 42% ± 1.9% (95% CI 6.6) of the
average 409 ± 46 somata (95% CI 52) per case within the levels observed. These somata form a
band that spans levels 28–30 through dorsal perifornical sub-regions, including the LHAjd,
LHAs, LHAd and, to a lesser extent, the LHAma. Although the LHAd was the area with the
highest average number of H/O-ir somata, with an average 96 ± 2.2 somata (95% CI 7.4) per
case, the LHAs is only one soma away with an average 95 ± 4.7 somata (95% CI 16) per case.
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This is more striking since this is a smaller region and therefore has the highest density of somata
(figure 7). Among the averages of the LHAs, LHAd and LHAjd they make up 67% of the total
average H/O-ir somata per case making these the regions with the greatest presence of these
somata. Other regions with a consistent presence of H/O-ir somata are the LHAvl, LHAvm at
level 30, DMHa from levels 28–30, and to a lesser extent the DMHp and DMHv at the same
levels.

Figure 6. Some regions containing consistent presence of αMSH. (A): Photomicrograph of the dorsomedial
hypothalamic nucleus (DMH) at level 30, which shows a consistent presence of αMSH-ir fibers. (B):
Photomicrograph of the paraventricular hypothalamic nucleus, descending division, forniceal part (PVHf), which
shows a consistent presence of αMSH-ir fibers and which also co-localizes with nNOS-ir neurons. (C):
Photomicrograph showing the staining profile of αMSH-ir somata within the arcuate hypothalamic nucleus (ARH).
Scale bars represent 100 µm. Please consult the Appendix for a list of terms corresponding to the anatomical
abbreviations shown in this figure.
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Figure 7. Examples of H/O-immunoreactive neurons in the perifornical lateral hypothalamic area (LHA). (A, C, E):
Photomicrograph of Nissl-stained sections with cytoarchitectural boundaries delineating aspects of the suprafornical
LHA region (LHAs) at atlas level 29 for three different animals. (B, D, F): Photomicrographs of tissue sections
DAB-stained for H/O (black) and nNOS (brown), which demonstrate the consistent high-density patterns of H/O-ir
somata found within the LHAs and LHAjd. Scale bars each represent 100 µm. Please consult the Appendix for a list
of terms corresponding to the anatomical abbreviations shown in this figure.
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Figure 8. Representative maps for levels 23–30 of H/O-ir somata and fibers. Please consult
the Appendix for a list of terms corresponding to the anatomical abbreviations shown in this
figure.
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Discussion of Aim 1
In this study, using rigorous cytoarchitectonic analysis, we have created detailed maps for the
distributions of H/O-, nNOS- and αMSH-ir neurons and their fiber systems. A number of studies
have examined the chemoarchitectural layout for each of the neuropeptides that was mapped in
this study. However, most of these studies were mapped using other atlases or were not mapped
to an atlas at all. The individual cytoarchitectural distributions of each of these neuropeptides are
in close agreement with many of the trends in the patterned distributions for these
immunoreactive cell groups that were previously reported. Validation of data by direct
comparison to data from these previous studies, however, is not possible. This is because the
maps that we have generated for nNOS or αMSH-ir somata and fibers have not been previously
mapped to any atlas and, more importantly, have not been mapped to the Swanson atlas (Rao et
al 1987, Kachaturian et al 1986, Jacobowitz and O’ Donohue 1978, Vincent and Kimura 1992,
Yamada et al 1996). From these previous studies, we can only glean similarities and differences
in the most obvious nuclei and compare the staining profiles between our studies and those
carried out for those nuclei. When examining H/O, however, we are able to refer to two major
works which have mapped the distributions of its mRNA and peptide presence in hypothalamic
neurons using the Swanson rat brain atlas (Swanson et al. 2005, Hahn 2010). Unfortunately
direct comparison of our results to these previous studies, however, is not easy to perform, due to
differences between the studies in how soma counts and statistical analyses were carried out. If
we were to take a simple average of totals, however, we find that in our study an average total of
409 H/O-ir somata, whereas Hahn 2010 reports an average of 257 H/O-ir somata. This
discrepancy is peculiar for two reasons. First, Hahn 2010 surveys atlas levels 25–33, which is a
rostrocaudal range that extends more caudally than the range examined in the present study (we
only analyze levels 23–30), these more caudal levels are known to contain even more H/O-ir
somata than more rostral levels. Second, Hahn 2010 used an antibody raised against pre-proH/O, which captures both H/O 1/A and 2/B, while we used an antibody raised against H/O 1/A
which should, in theory, label fewer H/O-ir somata, even if by a small margin. Taking these
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points into consideration, although the numbers may differ, the trends generally hold true
between the two studies, with the LHAd having the largest number of H/O-ir neurons, followed
by the LHAs and the LHAjd, respectively. For the most part, we find that all trends are in
general agreement within the atlas levels that overlap between these studies. This consistency
provides at least some degree of a convergence of evidence that has not been possible to achieve
prior to the mapping of this neuropeptide to the Swanson atlas. The ability to compare these
spatial distributions and patterns for neuropeptides demonstrates the merit not only of mapping,
but mapping to a common spatial framework which renders the data comparable in a common
spatial model, at least to a reasonable approximation. At the same time, limitations that arise
from differences in how the distributions were analyzed between the two studies underscores that
the standardization of these findings within the Swanson (2018) model could be refined further.
We reported counts based on averages and percentages with reported standard errors and
confidence intervals in order to be transparent about how the counts vary from case to case; this
variation, which can be accounted for in several ways, will be discussed. Reporting our
distributions in this way allows us to begin to move toward the development of a different type
of atlas, one that could be refined over time as replicates for maps of these peptidergic neuronal
distributions increase. Yet another difference between this study and those that came before it is
that here we have mapped the distributions for the fiber systems of H/O and αMSH systems to a
standardized atlas, in addition to their cell bodies.
Towards a probabilistic atlas
The reporting of these fiber systems within an atlas space allows for visualization of areas where
somata and fibers of two different neuropeptide systems co-distribute within the same brain
region, areas which can be designated as “Possible Synaptic Interaction Zones (PSIZs)” (Wells
2017). Within these PSIZs, there theoretically should be a higher probability of finding synaptic
contacts between the two neuropeptide systems being analyzed. This idea will begin to be put to
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the test in the second aim of this study. Future directions for this study include the generation of
refined consensus maps based on cell counts with the use of computational approaches to
determine what regions contain a higher consistency of somata and fibers for each neuropeptide
separately. The overlapping of these consensus maps will also be used to create maps of PSIZs
that are based on computational analysis, which is an improvement on previous iterations of
these maps, moving the Swanson rat brain atlas to a more probabilistic spatial model. In this
study, three animals were used for testing a neuropeptide combination of H/O + nNOS and
αMSH + nNOS immunostains, which would allow for the generation of maps demonstrating
regions of high and low variability in regional neuropeptide co-localization. Being able to
identify these PSIZs with higher confidence will allow researchers who want to study the
interactions of these neuropeptides to save time and effort and to narrow their search fields using
more refined methods such as patch-clamp electrophysiology, optogenetics and electron
microscopy; as they would be able to scan smaller regions in order to find neurons with the
synaptic interactions they are wishing to study in greater detail. This approach and outlook on
atlas-based mapping holds a lot of power and allows for testing of hypotheses which may have
profound implications in the way we view the development of the nervous system across species.
In the final analysis, however, the merit of a probabilistic atlas lies in its ability to accurately
predict trends and interactions across multiple animals. The realization of such a goal will
involve taking several sources of variability into account, and using computational tools to factor
in that variability to tease out the “ground truth” trends. The second innovation for proper use
and interpretation of these “ground truth” trends in peptide expression across animals will be the
mapping of these to a standardized 2-D atlas model which ideally could migrate to an interactive
3-D model. In this study, we have begun to lay the early groundwork for this daunting task to the
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best of our current abilities and within our time restrictions as students. Yet, we must
acknowledge that our approach still has much room for improvement and will only serve as a
prototype of what will hopefully be a long line of iterative versions that are to come.
Limitations of this study
Having considered the many benefits that the novel data presented provide, the current study is
not without room for improvement. As mentioned, we found a high level of variance between
somata counts for each peptide across all of the animals and staining combinations that were
performed. This normally would be solved in most other studies by increasing the number of
replicates to decrease both the standard error and tighten up the confidence intervals. For studies
that are as laborious and time-consuming as the one presented here, this is not always a feasible
endeavor. For this reason, many mapping studies do not provide statistical analysis of counts,
with their authors opting instead to report simplified counts that give graded intensities for
presence of a peptide by region. This approach does not give the fine detail of knowing which
regions and sub-regions are highly variable in their expression for the peptides being examined,
and which are of higher consistency and may be of importance (as those trends would be likely
to be more robustly preserved across animals). In reporting this variance, we hope to begin to
move toward a model of the brain which is more probabilistic, which is not possible without the
reporting of these details. The desire for a more probabilistic approach to mapping also opens up
the entire mapping process to scrutiny, for where exactly it is coming from? There are a large
number of sources where variance can come from for example, Simmons and Swanson 2010
which examines the importance of plane of section and histological processing for proper
representation on an atlas space. Even when taking the histology and plane-of-section into
account, there is also a variance that will come such as ours, which was inherently from
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individual interpretation at each step of the process. For a study conducted by a team of
individuals who interpret the data at different steps of the mapping process, we are not entirely
able to account for all of the origins of variance. This is yet another reason that we report the
standard errors and confidence interval, as these communicate the variability occuring within the
three replicates reported for these peptide distributions. Moving to a probabilistic atlas, however,
will require a progressive taming of the variables involved at every step of the mapping process.
This can begin by breaking up the process into three major phases: 1. immunohistochemistry; 2.
raw mapping; and 3. translation and representation. At each of these steps, there will be some
transformation of the data that is dependent on the interpretation of each individual. This can be
mitigated if each individual who maps is trained at the same time before mapping begins and the
same thresholds are established from the outset. If this is not done beforehand, as is the case in
this study, the post-acquisition option to account for these variables is to perform a qualitative
assessment in order to determine that these variations do not render the data incomparable. Such
a set of control experiments is a future direction that is currently being carried out for our study,
and which will be included for future publication but is not yet present in this dissertation.
Additional limitations for this study come from the immunoperoxidase staining method we used,
which does not allow for any co-expression analysis. This trade-off in immunohistochemical
staining merits consideration, as there is at least one report of somatic co-localization of nNOS
with H/O within the lateral hypothalamus of the rat (Cheng et al 2003). The immunoperoxidase
approach was used in this study in order to allow for the subsequent bright-field putative
apposition analysis that was carried out in Aim 2, without worry of fluorescence degradation, as
this analysis requires hours of exposure to light. Mislabeling is not of concern with this method,
due to the order of staining ensuring that the Ni2+-enhanced DAB precipitate is formed in H/O-ir
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somata before the DAB precipitate is formed in nNOS neurons. This ensures that only H/O-ir
somata appear as a black signal even if some H/O-ir somata may also have some brown staining
due to somatic co-localization with nNOS immunoreactivity. All animals used in this study were
fed ad libitum, meaning that the feeding state of these animals at time of perfusion was not that
of a fasted animal and the consistency across animals allows for control in this regard, with body
weights ranging between 302–375 g. All transcardial perfusions also took place within the same
window of time ranging between ZT 3–5.
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Aim 2: Mapping distributions of αMSH or H/O-ir axonal fibers apposed to
nNOS-ir somata in the hypothalamus
Objective
The objective of Aim 2 for this project is to generate detailed mapping of nNOS-ir somata
containing putative appositions from αMSH or H/O-ir fibers throughout Swanson atlas levels
23–30 containing the hypothalamus. In performing this mapping, we will be able to test the
hypothesis that nNOS-ir somata receive putative appositions from fibers of two peptides found in
different regions of the hypothalamus that are important for feeding control and metabolism. It
would stand to reason that αMSH and H/O, which are important neural substrates in the
hypothalamus for the control of feeding, drinking and the regulation of metabolism would exert
some effects on the modulation of feeding that is carried out by NO (Farr et al 2005, Sutton et al
2014, Morley and Flood 1992, Morley et al 2011). Generating these maps will allow us to begin
to identify where these interactions may be taking place and will begin to direct future efforts in
understanding the microcircuits these peptides may be forming within the hypothalamus.
Additionally, completing the objective of this portion of the project will help us to understand if
hypothalamic regions with co-localization of nNOS-ir somata and αMSH or H/O-ir fibers are
more likely to contain putative appositions.
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Animals

Methods

For this study, we used adult male Sprague Dawley rats as our animal model. Every animal was
housed in a temperature- and humidity-controlled vivarium under a 12 h:12 h light:dark
photoperiod (lights on at 7:00 A.M.). Animals were given access to food and water ad libitum.
All experiments were performed according to the NIH Guidelines for the Care and Use of
Laboratory Animals, and all protocols were approved by the Institutional Animal Care and Use
Committee of the University of Texas at El Paso. A total of four animals were used for this study
for all immunoperoxidase assays performed (n = 4).
Data analysis
Analysis of putative appositions
An Olympus BX53 light microscope (Olympus Corporation, Tokyo, Japan) coupled with a ×100
magnification objective lens (N.A., 1.25) was used for the analysis to confirm and map the
putative appositions for quantification. Once the image alignment and demarcation step was
finished and an Adobe Illustrator (AI) file was generated with a ×10 magnification stitched
photomicrograph of DAB-stained material, ellipses and hand-drawn fibers were used for
orientation during putative apposition analysis. This AI file was then opened in a computer
positioned next to the microscope in order to be able to easily go back and forth between the
oculars and open file. The initial orientation within the tissue was achieved under a ×10 objective
lens (N.A., 0.3) which was matched with a desired field of view on the open AI file containing
the ×10 magnification stitched photomicrograph of DAB-stained material. Once the desired field
of view was identified, the objective lens was changed to the ×100 magnification lens and
notable patterns of somata were then used as a reference in order to ensure that what was being
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viewed under the oculars was what was being analyzed on the AI file. The alignment of these
two views thus allowed for the observer to use the fine adjustment of the microscope to move up
and down through the focal plane in the z-axis through the tissue section at ×100 magnification,
visually inspecting each and every nNOS-ir soma to determine whether there were any αMSHor H/O-ir fibers found to be forming a putative apposition with it. Each individual performing
putative apposition analysis in this manner was given prior training and observed for the first two
atlas levels they analyzed. Special care was taken to ensure that each individual understood and
used the following criteria to determine all putative appositions (Krimer et al 1997, Lambe et al
2000): 1. Clearly identifiable soma and fiber within the same focal plane; 2. No visible space
observed between the fiber and soma in any focal plane; 3. The fiber can be followed in and out
of focus as it contacts the soma. Although these criteria are by no means exhaustive, they
provided a similar framework for each individual to assess the presence of what would be
considered a putative apposition. Whenever a cell was identified to have a putative apposition,
the fill color of the already mapped ellipse indicating a soma was changed to indicate the
putative apposition. If a soma was checked and found not to contain a putative apposition, then
the color of the stroke would be changed to indicate that the cell had been analyzed. In this way,
progress was able to be tracked and it was assured that no soma would be checked twice. At the
same time that this analysis was being performed, any discrepancies in the previously identified
and marked soma were corrected. In this way, all nNOS-ir somata counts were able to be refined
manually.
Translation of data to atlas plates
Data from the image alignment and demarcation step was not transferred to Swanson rat brain
atlas plates (Brain Maps 4.0; Swanson, 2018) until the putative analysis was completed for each
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atlas level. This ensured that all refined soma counts made their way onto the final atlas maps
and also ensured that the placement of putative appositions would line up exactly with the
locations of nNOS-ir somata. Transfers were then performed as before using the Lasso Tool, and
cell body and fiber demarcations from each hypothalamic sub-region were copied and pasted
onto corresponding atlas plates. These data were then transformed (scaling and rotation) as a
unit, to ensure that visual trends and relationships between data were preserved and remained
consistent with those observed in the tissue sections (Zséli et al., 2016). Adjustments to
accommodate regional distortions between the experimental tissue and the atlas representation
were approximated and applied to the data.
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Results
In this second aim, we used the Adobe Illustrator files containing the annotated photographs
produced for the first aim as a “road map” to keep track of our progress and identify where in the
tissue we were as we examined the tissue sections under the oculars at ×100 magnification.
These files contained ×10 magnification stitched images with an ellipse placed over each nNOSir soma throughout the entire hypothalamus. Using the stitched
photograph allowed us to have a broad, low-power view of where
we were as we checked each soma for appositions at ×100
magnification. Distinct somata, and the patterns they formed,
allowed us to match what we saw under the ocular with a specific
region in the stitched image in order to navigate where we were
in the tissue as we identified appositions. In this way, we were
able to mark each soma that contained what we considered to be a
putative apposition in accordance with the criteria outlined in the
methods (examples shown in Figure 9). This workflow allowed
us to retain the spatial information of each apposition and also
allowed us to refine our nNOS-ir somata counts. We found that
Figure 9. Examples of putative
appositions.
(A):
×100
magnification photograph of tissue
sections DAB-stained for H/O
(black) and nNOS (brown), which
provides an example of an H/O-ir
fiber forming a putative apposition
with an nNOS-ir soma. (B) ×100
magnification photograph of a
DAB-stained tissue section showing
an αMSH-ir fiber (black) forming a
putative apposition with an nNOSir soma (brown). The scale bar
represents 5 µm.

under high magnification, we were able to more accurately
observe two specific situations that led to undercounting and are
not apparent in the stitched photograph. The first of these was
when cells were found to overlap and create a false appearance of
a single soma where there were two or more, and the second was
when we observed some lighter-staining cells which may have
evaded detection when we used only the stitched image to map.
In contrast, we also had false positives, where an ellipse was

placed on a soma that seemed to have a very light staining profile in the stitched image but, when
observed under high magnification, there was nothing observed in that area. Overall, the team
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working on this study analyzed an approximate total of 29,700 somata throughout the entire
mediolateral and dorsoventral extents of the hypothalamus from levels 23–30 of the rat brain.
Due to time constraints in performing this this type of labor-intensive analysis, the same
procedure was not performed for H/O-ir somata; therefore, these counts may be slightly less
accurate than those for nNOSir somata. The procedures that were developed in this study for the
analysis and mapping of putative appositions is not one that is commonly practiced and,
therefore, the analysis of such data is not yet commonly established or explored. For this reason,
we will be providing various forms of analysis for these sets of data. Providing the maps of
putative appositions for a representative case gives the reader a sense of the spatial distribution
of these somata receiving putative inputs throughout the hypothalamus. These maps of nNOS-ir
somata with putative appositions were also placed alongside the maps of total somata at their
matching levels. This was done to demonstrate the total number of nNOS-ir somata present, to
give the reader a sense of how many of these have apposing αMSH-ir fibers (Figure 11). The
maps presented here, however, are representative, which means that these are only from a single
case. To augment our analysis of relative percentages, I have received a dot plot from Dr. Sivasai
Balivada, a post-doctoral fellow in Dr. Arshad Khan’s laboratory, which summarizes the relative
percentages of the total nNOS-ir somata per region and level, along with the relative percentages
of nNOS-ir somata receiving putative axonal inputs across three cases (Figure 12). This will be
reviewed in detail below.
Visual trends
αMSH-ir fibers– nNOS-ir somata: visual distributions of putative appositions.
A cursory examination of the maps presented in Figure 10 suggests that more caudal
levels contain higher numbers of nNOS-ir somata with αMSH-ir fibers forming putative
appositions with them. It also becomes apparent that more periventricular zone regions seem to

45

contain large numbers of nNOS-ir somata with putative apposing αMSH-ir fibers, which also
coincides with the regions containing the most constant densities of αMSH-ir fibers. This
indicates that, for the most part, those regions where nNOS-ir somata co-localize with higher
densities of αMSH-ir fibers will also be regions where these somata receive higher number of
αMSH-ir putative appositions, which would be expected but is not the only possible case.
Likewise, in these maps it is very appreciable that neurons in most subdivisions of the PVH
contain a high density of nNOS-ir somata with putative apposing αMSH-ir fibers. This is evident
across the rostrocaudal extent of the PVH in the levels sampled, including in the PVHap,
PVHpv, PVHdp, PVHpmm, PVHmpd and PVHmpv. One notable exception to this PVH trend is
the PVHlp, which is almost devoid of nNOS-ir somata with putative apposing αMSH-ir fibers
across all cases. This absence is in stark contrast to the consistently high density of these putative
appositions in the adjacent PVHf and, to a much lesser extent, in PVHmpd at level 27. In fact,
the PVHf draws the viewers’ attention almost immediately as an area of notably high density for
these putative appositions at level 27. The more rostral lateral zone has a consistent presence of
nNOS-ir somata with putative appositions from αMSH-ir fibers in sub-regions such as the
LHAai and LHAav, which also contain the highest numbers of nNOS-ir somata. More caudal
levels show an increase in the presence of nNOS-ir somata with putative apposing αMSH-ir
fibers in more medial LHA subdivisions, such as the LHAjd, LHAjvd, LHAjvv and LHAs; with
the greatest of these being the LHAjvd and LHAjvv at levels 29 and 30. There is also a sparce
but consistent presence of at least some nNOS-ir somata with putative apposing αMSH-ir fibers
in the VMHvl and VMHc, with a noticeable decrease of presence in the VMHdm and a full
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Figure 10 (above and also previous page). Representative maps of Swanson atlas levels 23–30 for
nNOS-ir somata receiving putative contacts from αMSH-ir fibers (left column), placed adjacent to
representative maps for the same brain at the same levels showing all nNOS-ir somata (right column)
in order to facilitate comparison. Please consult the Appendix for a list of terms corresponding to the
anatomical abbreviations shown in this figure.
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absence in the VMHa, which is due to the fact that these sub-regions do not contain as many
nNOS-ir somata (Figure 10). At the most caudal levels (28–30), there is also a consistent density
of these nNOS-ir somata with putative appositions from αMSH-ir fibers in the DMHa, DMHp
and, more noticeably, in the DMHv, which has a consistent higher density of αMSH-ir fibers
than the adjacent DMHp. Interestingly, at level 29 there also seems to be a higher density of
nNOS-ir somata with putative appositions; specifically, in the medioventral tip of the DMHa,
which seems to carry on into level 30 in the DMHv. Sub-regions which contain little to no
presence of these nNOS-ir somata with apposing αMSH-ir fibers are the more ventral
periventricular zone regions, such as the PVa, PVpo and the PVi. The AHNa, AHNc and AHNd
contain very few appositions across cases, which also coincides with a sparse number of nNOSir somata. In this same way, the ARH is noticeably devoid of any nNOS-ir somata with putative
appositions, as there is very little to no presence of nNOS-ir somata in the ARH across all levels
and cases.
H/O-ir fibers– nNOS-ir somata: visual distributions of putative appositions.
When taking a general visual survey of the nNOS-ir somata with putative appositions from H/Oir fibers, it becomes apparent that there is an almost ubiquitous representation of appositions
throughout the rostrocaudal extent of the levels surveyed. Interestingly, when examining levels
23 and 24, the greatest densities of nNOS-ir somata with putative appositions from H/O-ir fibers
can be observed in the more lateral regions, where the fiber densities of H/O-ir fibers appears
sparse across all three cases. This suggests that there might be a more deliberate targeting of
these lateral nNOS-ir somata by H/O-ir fibers traveling rostrally across the LHAav and LHAai.
Rostral levels 23–26 also seem to show a biased innervation of H/O-ir fibers toward nNOS-ir
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somata, especially in more dorsally situated hypothalamic sub-regions, such as the MPO, LHAjp,
LHAad, LHAai, PVHap, PVHdp, PVHmpd, PVHpmm, PVHmpv, and to a lesser extent the
PVHpml. Many of these regions overlap with nNOS-ir somata receiving putative appositions
from αMSH-ir fibers, which is a theme that will be pointed out, for some other sub-regions.
More caudally, at levels 27–30, there is a shift from the presence of nNOS-ir somata receiving
H/O-ir fibrs in more dorsal regions to more ventral sub-regions; this shift occurs gradually shifts
as one examines the levels rostrocaudally. Another shift that happens when moving in a
rostrocaudal direction through these levels is an increase in the presence of nNOS-ir somata with
putative appositions from H/O-ir fibers in the more medial zone sub-regions, which is most
prominent at the most caudal levels (29, 30). The AHN also has a rostrocaudal shift which is not
as dramatic but which is still noticeable, with low densities of nNOS-ir somata with putative
appositions from H/O-ir fibers present within the AHNa, AHNc and AHNp from levels 23–25.
These interactions become completely absent from the AHNp at level 26 and from the AHNc
and AHNd at level 27. Again, just as for several other PVH sub-regions that have been pointed
out above, the PVHf at level 27 is another area which has co-spatial presence of nNOS-ir somata
with putative appositions from αMSH-ir fibers or H/O-ir fibers, although the presence of
appositions from H/O-ir fibers is much less consistent and occurs at far fewer detectable nNOS-ir
somata. This is a theme that also carries on through other caudal LHA and DMH sub-regions,
including at the more caudal levels of the LHAjd and at all levels of the LHAjvd, LHAjvv,
LHAs, LHAd, DMHa and DMHp. When examining sub-regions of the VMH, there is also a
similar distribution of nNOS-ir neurons receiving H/O-ir putative appositions to that of nNOS-ir
somata receiving putative appositions from αMSH-ir fibers. Especially consistent are presence
of nNOS-ir somata with putative appositions from H/O-ir fibers in the VMHc and VMHvl
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Figure 11 (above and also previous page). Representative maps for levels 23–30 of nNOS-ir somata
receiving putative contacts from H/O-ir fibers (left column), placed adjacent to representative maps
for the same brain at the same levels of nNOS-ir somata (right column), in order to facilitate
comparison. Please consult the Appendix for a list of terms corresponding to the anatomical
abbreviations shown in this figure.
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throughout caudal levels 27–30, and a much lower presence of these somata in the VMHa and
VMHdm. The thalamic ZI is a region that contains a sparse number of nNOS-ir somata, which
also makes sense from the standpoint of somata receiving putative appositions from H/O-ir
fibers; however, at level 27, the medial tip of the ZI shows a small distribution of nNOS-ir
somata with putative appositions consistently across all cases.
Semi-quantitative analysis of appositions
Taking a more quantitative approach to the analysis of the distributions of these nNOS-ir somata
with putative appositions from either αMSH- or H/O-ir fibers allows for a different perspective
than simply one of gauging the total presence of somata per region. When examining regions not
in terms of the presence of these appositions but in terms of examining the relative percentages
of these appositions with respect to the total number of nNOS-ir somata per region, we are able
to see which of these hypothalamic regions have more precise targeting by αMSH- or H/O-ir
fibers. The counts for both the total number of cells and those with appositions from
immunoperoxidase-stained fibers were obtained from the atlas maps presented in Figure 11.
These atlas maps were populated from hand-annotated stitched photomicrographs of
immunoperoxidase-stained tissue sections created by my undergraduate student assistants, and
later refined under the microscope at ×100 magnification. Special care was taken to place each of
these cells into their corresponding hypothalamic sub-region to provide the most accurate counts
possible. Additionally, this process was replicated in three different animals and the numbers
presented here are derived from those three animals, including standard errors and a 95%
confidence intervals, which are not commonly reported among studies of this nature. The counts
presented here are useful to gain an understanding of the relative proportions of neurons per
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region and the proportion of those neurons which receive input from the two neuropeptides
observed in this study. The dot plots which visualize these trends are presented in Figure 11 and
were kindly provided by Dr. Sivasai Balivada; these will be referenced throughout the next
sections.
αMSH-ir fibers– nNOS-ir somata: semi-quantitative analysis
Taking a quick survey of the relative percentages for nNOS-ir somata with putative appositions
from αMSH by level, we are able to ascertain that these confirm the visual trends described
above in addition to refining those observations. The greatest percentages for these apposed
somata are found at levels 25, 29 and 30 which contain 13.2% ± 3.33% (95% CI 11.3), 14.8% ±
4.02% (95% CI 13.6) and 24.3% ± 6.84% (95% CI 23.2) of the total number of αMSH-ir fiber
appositions onto nNOS-ir somata; which, in turn, account for 2.23% ± 0.6% (95% CI 2.06),
2.14% ± 0.48% (95% CI 1.63) and 3.43% ± 0.82% (95% CI 2.8) of the total number of nNOS-ir
somata, respectively. This is visually appreciable in Figure 12B, which shows the percent of
nNOS-ir somata with putative appositions from αMSH-ir fibers (inner circle) with respect to the
total percent of nNOS-ir somata per level (outer circle). When examining the regions with the
highest relative percentages of nNOS-ir somata with αMSH-ir fibers apposing them, the LHA as
a whole seems to contain the largest percentage of these cells. Breaking the LHA down into its
sub-regions, we can see that the LHAav and LHAjvv have some of the highest relative
percentages of appositions, making up an average of 53 ± 14.6 (95% CI 49.6) and 47 ± 7.2 (95%
CI 24.4) nNOS-ir somata with αMSH-ir fibers apposing them, respectively. These apoositions
make up an average of 6.03% ± 1.08% (95% CI 3.7) and 5.98% ± 0.77% (95% CI 2.6) of all
appositions from αMSH-ir fibers, and correspond to 1.02% ± 0.43% (95% CI 0.86) and 0.94% ±
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0.22% (95% CI 0.44) of total nNOS-ir cells. Thus, the LHAav displays the highest percentage of
these cells, with the LHAjvv in fourth place, after the DMHa and DMHv. Even though the LHA
does have the largest amount of nNOS-ir somata with appositions from αMSH-ir fibers, Figure
12B clearly shows that relative to the total percentage of somata in the LHAav and LHAjvv,
there are far less somata with appositions than in periventricular regions such as the DMH and
PVH. The relative size of these regions also merits mention, as the LHA takes up a significantly
larger area of the hypothalamus than do the DMH or the PVH. The DMHa was observed to
harbor the second-highest number of nNOS-ir somata with appositions from αMSH-ir fibers
after the LHAav, with an average total of 49 ± 8.7 (95% CI 29.5) somata comprising an average
of 6.9% ± 1.73% (95% CI 5.85) of total nNOS-ir somata with appositions from αMSH-ir fibers.
These cells account for 1.02% ± 0.35% (95% CI 0.69) of all nNOS-ir somata. Following DMHa,
the DMHv contains the third-highest number of appositions from αMSH-ir fibers onto nNOS-ir
somata, with an average of 47 ± 10.4 (95% CI 35.4) somata containing these appositions, which
is an average of 7.1% ± 1.78% (95% CI 6.06). These cells comprise 0.96% ± 0.37% (95% CI
0.74) of total nNOS-ir somata. Finally, the third hypothalamic region with a large representation
of nNOS-ir somata with appositions from αMSH-ir fibers is the PVH, which has the highest
number of these within the PVHmpd, PVHap and PVHpv. Each of these sub-regions contained
an average of 44 ± 12 (95% CI 42.2), 30 ± 9.25 (95% CI 31.4) and 20 ± 4.67 (95% CI 15.9)
somata, respectively, with αMSH-ir fibers apposing them, which are an average of 5.11% ±
1.35% (95% CI 4.58), 4.11% ± 1.48% (95% CI 5.03) and 2.4% ± 0.51% (95% CI 1.73) of all
nNOS-ir somata with putative appositions from αMSH-ir fibers. These cells comprise 0.85% ±
0.4% (95% CI 0.78) and 0.61% ± 0.33% (95% CI 0.65) of all nNOS-ir somata. One last region
which is of note even if to a lesser extent by numbers than some other sub-regions, is the VMHvl
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which had an average of 25 ± 5.37 (95% CI 18.2) cells, which may be of interest when
comparing and contrasting nNOS-ir somata with putative appositions from H/O-ir fibers.
H/O-ir fibers– nNOS-ir somata: semi-quantitative analysis
In contrast to αMSH-ir fibers, which seem to contact nNOS-ir somata with more frequency at
periventricular zone regions, H/O-ir fibers appear to contact nNOS-ir somata in more lateral zone
regions especially at more rostral levels, which coincides with the visual trends noted above.
When examining the percentages by rostrocaudal level of nNOS-ir somata with H/O-ir fibers
apposing them, one can quickly appreciate that atlas levels 23–25 (Figure 12A) contain the
largest relative percentages of these appositions with 3.55% ± 0.68% (95% CI 2.3), 2.67% ± 0.91
(95% CI 3.1) and 3.5% ± 1% (95% CI 3.38) of total nNOS-ir somata, respectively. When
examining the percentage of total nNOS-ir somata with appositions from H/O-ir somata,
however, one can observe that levels 23, 25 and 29 are those with the greatest average
percentages of appositions onto these neurons, with 19.2% ± 1.43% (95% CI 4.88), 16.7% ±
1.55% (95% CI 5.25) and 13.03% ± 1.8 (95% CI 6.1) neurons, respectively. These numbers
indicate that H/O-ir fibers appear to target levels 23–25 more directly, as these have the highest
relative percentages. However, the largest percentage of the total number of nNOS-ir somata
with putative appositions from H/O-ir fibers are found at levels 23, 25 and 29. Much as for
αMSH-ir fibers, it seems that H/O-ir fibers also form putative appositions onto nNOS-ir somata
in high percentages in the LHA, PVH and DMH. However, when it comes to H/O-ir fibers
forming putative appositions onto nNOS-ir somata, the LHA has a much larger representation of
these appositions throughout more rostral levels. Examining the cell counts for H/O-ir fiber
appositions with nNOS-ir somata, one observes that the LHAav, LHAai and LHAjp had the
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highest average numbers, with 164 ± 43.5 (95% CI 147.8, 79 ± 23.8 (95% CI 80.9) and 69 ± 18.7
(95% CI 63.3) somata per case, respectively. These counts correspond to 15% ± 0.67% (95% CI
6.8), 7% ± 0.52% (95% CI 3.23) and 6.3% ± 0.27% (95% CI 2.74) of the total number of nNOSir somata with putative appositions from H/O-ir fibers; and 3.25% ± 1.56% (95% CI 3.05),
1.53% ± 0.88% (95% CI 1.73) and 1.22% ± 0.71 (95% CI 1.39) of total nNOS-ir somata,
respectively. These hypothalamic sub-regions account for both the largest percentages of total
putative appositions from H/O-ir fibers with nNOS-ir somata, and the largest percentages of total
nNOS-ir somata. Thus, not only are these areas being targeted in large numbers but are also
being targeted more directly, likely indicative of a strong form of interaction between H/O-ir and
nNOS-ir cell populations in these rostral LHA sub-regions. After the LHA subdivisions which
hold the highest counts and percentages for nNOS-ir somata with putative appositions from H/Oir fibers, the VMHvl has the sixth-highest number of counts for these, with an average of 41 ±
13.2 (95% CI 44.9) somata; which account for an average 3.59% ± 0.36% (95% CI 1.8) of all
H/O fibers apposed to nNOS-ir somata and 0.86% ± 0.47 (95% CI 0.93) of total nNOS-ir
somata. The VMHvl, as mentioned above, was also observed to contain putative appositions
from αMSH-ir fibers with a similar representation. Other hypothalamic sub-regions with
representations from both H/O and αMSH-ir fibers apposing nNOS-ir somata are the PVHmpd,
DMHa and DMHv, each of which have 25 ± 7.5 (95% CI 25.6), 24 ± 3.8 (95% CI 13.1) and 23.6
± 9.34 (95% CI 31.7) nNOS-ir somata with appositions from H/O-ir fibers, respectively (Figure
12A). These numbers account for 2.4% ± 0.22% (95% CI 0.78), 2.8% ± 0.08% (95% CI 0.74)
and 2% ± 0.42% (95% CI 1.47) of nNOS-ir somata with appositions from H/O-ir fibers; and
0.51% ± 0.28% (95% CI 0.54), 0.48% ± 0.14% (95% CI 0.27) and 0.49% ± 0.34% (95% CI
0.67) of total nNOS-ir somata, respectively. As mentioned in the trends section, the PVHf does
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have a small amount of overlap in nNOS-ir somata with putative appositions from both αMSHand H/O-ir fibers. However, the putative appositions from the latter are far less consistent and
also fewer in number, with an average of only 7 ± 2.46 (95% CI 8.34) nNOS-ir somata with
putative appositions per case, accounting for 0.69% ± 0.08 (95% CI 0.29) of all nNOS-ir somata
with H/O-ir putative appositions, and 0.15% ± 0.09% (95% CI 0.18) of all nNOS-ir somata. The
thalamic ZI is yet another area which differs between nNOS-ir somata with αMSH-ir putative
appositions and those with H/O-ir putative appositions, with many more H/O-ir fibers apposing
nNOS-ir somata than αMSH-ir fibers apposing them. In the case of H/O-ir fibers apposing
nNOS-ir somata of the ZI, we find that, on average, there are 31 ± 5.2% (95% CI 17.8) of these
intractions, which make up 3.6% ± 0.1% (95% CI 1) of all nNOS-ir somata with appositions
from H/O-ir fibers, and 0.62% ± 0.19% (95% CI 0.37) of all nNOS-ir somata. ZI nNOS-ir
somata with appositions from αMSH-ir fibers averaged 10 ± 1 somata (95% CI 3.46), which
comprises only 1.38% ± 0.17 (95% CI 0.6) of all nNOS-ir somata with αMSH-ir fibers apposing
them and 0.27% ± 0.2 (95% CI 0.06) of total nNOS-ir somata. Finally, as a general observation
of the total percentages of putative appositions from H/O- and αMSH-ir fibers, it appears that
H/O-ir fibers may contact a higher percentage of nNOS-ir somata, being that H/O-ir fibers had
putative appositions with an average of 18.8% of all nNOS-ir somata, while αMSH-ir fibers only
contacted 15.8% of all nNOS-ir somata.
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A

B

Figure 12. Bar graph and dot plot representations of relative percentages for nNOS-ir somata found to contain
putative contact from either (A) H/O- or (B) αMSH-ir fibers. Please consult the Appendix for a list of terms
corresponding to the anatomical abbreviations shown on these charts. Charts provided courtesy of Dr. Sivasai
Balivada of the Khan laboratory.
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Discussion of Aim 2
When taking a survey of studies concerned with putative appositions it becomes apparent that the
majority of these very elegant and well-constructed studies focus on testing and reporting how
many and where on single neurons these putative appositions are being formed (Belmer et al
2017, Benavides-Piccione et al 2005, Voss et al 1990, Potrebic et al 1995, Meng et al 1997,
Krimer et al 1997, Lambe et al 2000). Additionally, these studies normally use a small subset of
the population of neurons they are interested in and do not indicate where within the brain region
of interest these neurons came from. Of course, this is not the intent in any of these studies,
whose purpose is to instead provide a detailed analysis of single neuron appositions indicating
exactly how many and where these appositions are located throughout the entirety of single
neurons. This allows for analysis of what effects the placement and quantity of putative
appositions may have on communication between the two neuronal populations being observed.
Here, we have opted for an analysis at an intermediate scale to refine the region-wide spatial
resolution of the data we collect while foregoing the detailed studies of appositions at singleneuron resolution. The mapping of these mesoscale putative interactions to a standardized atlas is
not commonplace and has never been performed, to our knowledge, in this manner, i.e., using
the Swanson rat brain atlas. In moving to this intermediate scale, we were able to report a highspatial resolution analysis of the nNOS-ir neurons which contain putative synaptic interactions
from αMSH- or H/O-ir axonal fibers on a regional level, as well as across multiple rostrocaudal
levels. A comparison of the maps generated in this second aim to the forthcoming maps of PSIZs
in the first aim will begin to test the probabilistic model of mapping the rat brain that is being
proposed here and was proposed previously in Wells 2017. Subsequent testing of the robustness
of the maps generated in this study will come from the scientific community through
experimental targeting of the predicted locations of the neurons mapped in our study, using
optogenetics, chemogenetics, electron microscopy as well as some forms of neuronal tracer
studies.
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Data implications
αMSH and H/O are two peptide neurotransmitters at the center of hypothalamic feeding circuitry
and are affected by a number of different neuromodulators coming both from the periphery as
well as those present within the hypothalamus. One of these is the gaseous retrograde
neurotransmitter, nitric oxide, which is generated by the nNOS enzyme. As mentioned in the
introduction, each of the two neuropeptides and enzyme observed in this study have been shown
to play some role in feeding and metabolic regulation. αMSH is present in first-order neurons of
the ARH which interact with molecular signals from the periphery including insulin, ghrelin, and
leptin; among others (Cone 2005, Simerly 2015, Yu and Kim 2012, Saper and Lowell 2014).
Intracerebral administration of H/O is enough to induce an increase in feeding of sated rats and
mice (Choi et al 2010, Kotz et al 2002, Lubkin and Stricker-Krongrad 1998), which is an effect
that can be decreased when there is intracerebroventricular (ICV) administration of an nNOS
inhibitor, such as L-NAME, or a knockout of nNOS in mice (Farr et al 2005). nNOS also
modulates the feeding effects of other feeding signals such as ghrelin and the levels of nNOS are
decreased when NPY is ICV administered (Morley et al 1999, Gaskin et al 2003). Thus, there is
some precedent for the hypothesis that nNOS cells are contacted by peptide neurotransmitters
which mediate feeding, such as αMSH and H/O. In this aim, we provide evidence of putative
appositions from αMSH- or H/O-ir fibers with nNOS-ir somata within various hypothalamic
sub-regions at levels 23–30 of the Swanson (2018) atlas. Interestingly, appositions from both
αMSH- and H/O-ir fibers with nNOS somata overlap within some very interesting regions. One
of these is the PVH, where nNOS has been found to comprise a subset of Sim1-expressing
neurons in mice which coincidentally also express the αMSH-sensitive receptor, MC4R (Sutton
et al 2014). Sim1-. MC4R-expressing neurons have also been found to regulate energy
expenditure through glutamatergic stimulation, which leads to a decrease in feeding and an
increase in energy expenditure in mice (Xu et al 2013). The nNOS-expressing PVH subset of
Sim1 neurons were also found to project to hindbrain and spinal cord regions that govern food
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intake and energy expenditure (Sutton et al 2014). These studies all begin to build a more
complete narrative of nNOS-mediated PVH feeding control and metabolic regulation, a narrative
that is consistent with the observations we have made, which suggest possible additional
regulation through opposing anorexigenic and orexigenic signaling from ARH-originating
αMSH and LHA-originating H/O. However, these studies were conducted using the mouse as a
model, which does not always translate in the same way to the rat model. The mapping of the
putative interactions between these neuron populations has generated testable hypotheses which
need to be tested in the rat model. Another region that needs to be addressed is the DMH, which
was found to also contain nNOS-ir somata with putative contacts from both αMSH- or H/O-ir
fibers. Retrograde injections that were made in the DMH and mapped to the Swanson rat brain
atlas (Thompson and Swanson 1998) show that there are retrogradely labeled cells within the
ARH and LHA, in areas where we observed αMSH- and H/O-ir somata to be located. Within the
DMH, there is a large population of neuropeptide Y (NPY)-immunoreactive somata that have
been implicated in the control of portion size during feeding. When the presence of this
neuropeptide is decreased within the DMH using AAV directed knock-down there was also an
increase in the production of brown adipose tissue and a decrease in obesity (Mercer et al 2011).
It would stand to reason, then, that there is a possibility that some of these DMH NPY neurons
may co-express nNOS and could be the neuron populations being contacted by αMSH or H/O-ir
fibers either independently or onto the same somata. The VMHvl is also a region of some
overlap for putative appositions from both αMSH- and H/O-ir putative appositions with nNOS-ir
somata. Neurons here have been implicated in the detection of hypoglycemia in order to induce
the counterregulatory response (CRR), which is a self-preservation mechanism mediated by
coordinated neuroendocrine and autonomic inputs that prevents the brain from suffering damage
due to low glucose levels (Fioramonti et al 2010). There are multiple studies that have been
carried out on VMH nNOS glucose-inhibited neurons which implicate these in a variety of
energy homeostatic processes which are affected by the presence of peripheral signals such as
insulin, leptin and of course glucose (Canabal et al 2007a, Canabal 2007b, Zhou et al 2018).
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Interestingly, neurons of the VMHvl have also been observed to mediate aggression in both mice
and rats (Olivier 1976, Yang et al 2017). This observation is in agreement with separate studies
that have observed that albino rats, when food-deprived, will have an exaggerated aggressive
response to foot shock; a behavior that may even be linked to a neuronal subpopulation that helps
the animal mediate aggression in order to secure food in low-energy states (Cahoon et al 1971).
These studies implicate nNOS, αMSH and H/O in the modulation of these two possibly linked
responses of aggression and metabolic response to low glucose levels. Advances built on each of
these published observations, together with our findings here, are predicated on two major future
directions. The first of these is to determine if nNOS-ir somata also stain for the presence of the
melanocortin receptors, MC4R and/or MC3R. Second, it would be worth investigating which
other neuropeptides may co-localize within the same somata as nNOS in these regions of
interest. In the case of the PVH, this could be oxytocin and the vesicular glutamate transporter
(VGLUT); for the DMH, it could be NPY; and, in the case of the VMHvl, this could be the
progesterone

receptor

(PR).

Many

of

these

may

be

difficult

to

identify

using

immunocytochemistry, due to receptors and transporters being notoriously difficult to label
specifically, and NPY requiring the use of colchicine for visualization it within the soma. An
alternative approach might be to use a combination of immunocytochemistry with in situ
hybridization probes against the mRNA sequences encoding these neuropeptides, to begin to
elucidate which of these co-localize with nNOS-ir somata. Each of these testable hypotheses that
emerge from our Aim 2 studies speak to the value of conducting a large-scale survey for putative
interactions to shed light on intra-regional circuits. More importantly, this work helps to put the
spatial model that is the Swanson rat brain atlas to the test. The validation of these maps of
putative appositions will no doubt be performed by those who want to use these maps to narrow
their search for these putative contacts using higher magnification techniques such as electron
microscopy (EM), which is a future direction of this study. We plan to provide the maps and
charts we have generated here to a collaborator who will use them to try to obtain high-power
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EM photomicrographs to provide evidence that these maps identify areas where there is higher
likelihood to find synaptic contacts between these neuronal subsets.
Limitations of this study
Perhaps the most serious limitation of this second aim is that we are using light microscopy in
order to determine which neurons we consider to contain putative appositions. While this is
appropriate, the method does not permit further refinement of such identification so that we
could say with certainty that the seemingly apposing elements (soma and axonal fibers) we are
observing are indeed forming a synapse. We were also limited in this regard by our choice of
immunocytochemical procedure, as we are unable to stain for and visualize a third peptide that
might lend more credence to these claims, such as post-synaptic density 95 (PSD95). This,
however, will be addressed through the use of EM and will be added in future studies. One might
ask: “Why is providing maps of these unconfirmed synaptic interactions with the resolution used
is of merit?”, and the answer is that it provides a survey of the larger areas in order for more
targeted and direct searches with more precise tools. These techniques can then help
investigators to explore and either confirm or deny and thereby refine the probabilistic model
which we are working toward. The findings presented in this second aim present very similar
issues concerning variability and therefore may have many of the same limitations as Aim 1.
However, as stated in the first aim, the hope is that by being transparent with our numbers and by
mapping to a standardized atlas, we are able to provide the reader with the tools to test and refine
the model that we are presenting here. Many of the same sources of variability from Aim 1 also
apply to the studies performed in this second aim. This new form of analysis also introduces one
new step that is open to the interpretation of each individual and that is the interpretation of
putative appositions. For this step, everyone involved in observing putative appositions under
high power magnification in the microscope was trained on how to determine if an axonal fiber
met all of our pre-established criteria in order to be designated as a putative apposition. Although
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this mitigated the variance in consensus for determining putative appositions, we cannot say that
it completely accounted for or eliminated it. The task was also complicated by the
immunocytochemical staining of nNOS, which in some regions of the hypothalamus displays
signal that only makes part of the somatic circumference visible. This may have led to
undercounting of some nNOS somata which may have had putative appositions from αMSH- or
H/O-ir fibers. All student assistants aiding in this aspect of the project were instructed to be
overly cautious with the labeling of nNOS-ir somata as containing putative appositions. The
reason for this is that we viewed the generation of these maps as a product that would hopefully
be used by the scientific community in order to explore the hypotheses that arise from the data
collected. Due to this, we opted to minimize reporting of false positives as a tradeoff for possibly
underrepresenting of nNOS somata with putative appositions from αMSH- or H/O-ir fibers.
Concluding remarks
Here we have presented high-spatial resolution cytoarchitecturally-based maps for the
chemoarchitectural distributions of neurons expressing nNOS, αMSH and H/O and for the
nNOS-ir somata which were found to contain putative appositions from αMSH or H/O-ir fibers.
These maps span the full mediolateral and dorsoventral extent of the hypothalamus spanning
levels 23–30 of the Swanson rat brain atlas. In Aim 1 we were able to test the hypothesis that
peptide distributions would be variable across different brains while at the same time containing
some regions of consistency which could be assessed by rendering these brains comparable using
a common spatial framework (Swanson 2018). The peptide neurotransmitters and enzyme that
were chosen for this study all have been implicated in different aspects of feeding control and
metabolic regulation, among other functions. Due to the variety of functions for these peptides,
we chose to narrow our scope and focused on the feeding roles of these peptides for analysis and
interpretation of our results. However, without a doubt there are many more behaviors and
physiological processes that can be explored using the maps that were generated in Aim 1 of this
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study. The second aim of this study was developed to test the hypothesis that nNOS-ir somata
throughout different regions of the hypothalamus would contain putatively apposing αMSH- or
H/O-ir axonal fibers probably originating from the ARH and various LHA sub-regions. These
experiments have generated hypotheses which may be further explored by our own laboratory or
others using different techniques. In performing these studies, we have taken an exploratory,
discovery-based approach to research that has allowed for the development of a dataset that can
be used as a tool to conduct further hypothesis-driven research. Even though the current study
was framed in a hypothesis-driven manner, it is also important to acknowledge that there was a
large exploratory aspect to the experimental design presented here. Open exploration of different
regions and peptide combinations allowed for a wide net to be cast which then returned datasets
that can now be explored in a more hypothesis-driven way. Most importantly, each of these
datasets were migrated onto a standardized atlas that allows for a method of reporting data which
renders them comparable in space with any other dataset that is mapped into the same atlas
space. In the case of the Swanson rat brain atlas, this includes numerous tract-tracing and
chemoarchitectural studies that can now be brought into register, as was done here with Hahn
2010. Having a common spatial framework will allow for continuous addition of different
peptide combinations and animals that will make the creation of a probabilistic atlas a
possibility. The populating of a standardized probabilistic model of the locations for all
neuropeptide-expressing neurons that mediate some aspect of neuronal transmission will allow
for the refinement of our understanding of the brain in a way that will hopefully unify the efforts
of neuroscientists around the world.
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Appendix: List of Neuroanatomical Abbreviations
AAA

anterior amygdalar area

AHA

anterior hypothalamic area

AHN

anterior hypothalamic nucleus

AHNa

anterior hypothalamic nucleus anterior part

AHNc

anterior hypothalamic nucleus central part

AHNd

anterior hypothalamic nucleus dorsal part

AHNp

anterior hypothalamic nucleus posterior part

ARH

arcuate hypothalamic nucleus

BST

bed nuclei of terminal stria

DMH

dorsomedial hypothalamic nucleus

DMHa

dorsomedial hypothalamic nucleus anterior part

DMHp

dorsomedial hypothalamic nucleus posterior part

DMHv

dorsomedial hypothalamic nucleus ventral part

l

internuclear hypothalamic area

MPNl

medial preoptic nucleus lateral part

MPNm

medial preoptic nucleus medial part

MPO

medial preoptic area

LHA

lateral hypothalamic area

LHAad

lateral hypothalamic area anterior group anterior region dorsal zone

LHAai

lateral hypothalamic area anterior group anterior region intermediate zone

LHAav

lateral hypothalamic area anterior group anterior region ventral zone

LHAd

lateral hypothalamic area middle group lateral tier dorsal region

LHAjd

lateral hypothalamic area middle group medial tier juxtadorsomedial region
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LHAjp

lateral hypothalamic area middle group medial tier juxtaparaventricular region

LHAjvd

lateral hypothalamic area middle group medial tier juxtaventromedial region dorsal
zone

LHAjvv

lateral hypothalamic area middle group medial tier juxtaventromedial region ventral
zone

LHAma

lateral hypothalamic area middle group lateral tier ventral region magnocellular
nucleus

LHApc

lateral hypothalamic area middle group lateral tier ventral region parvicellular
region

LHAs

lateral hypothalamic area middle group perifornical tier suprafornical region

LHAsfa

lateral hypothalamic area middle group perifornical tier subfornical region anterior
zone

LHAsfp

lateral hypothalamic area middle group perifornical tier subfornical region posterior
zone

LHAvl

lateral hypothalamic area middle group lateral tier ventral region lateral zone

LHAvm

lateral hypothalamic area middle group lateral tier ventral region medial zone

MEAad

medial amygdalar nucleus anterodorsal part

PH

posterior hypothalamic nucleus

pofh

hypothalamic postcommissural fornix

PVa

periventricular hypothalamic nucleus anterior part

PVHap

paraventricular hypothalamic nucleus parvicellular division anterior parvicellular
part

PVH

paraventricular hypothalamic nucleus

PVHdp

paraventricular hypothalamic nucleus descending division dorsal parvicellular part

PVHf

paraventricular hypothalamic nucleus descending division forniceal part

PVHlp

paraventricular hypothalamic nucleus descending division lateral parvicellular part
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PVHmpd

paraventricular hypothalamic nucleus parvicellular division medial parvicellular
part dorsal zone

PVHmpdl paraventricular hypothalamic nucleus parvicellular division medial parvicellular
part dorsal zone lateral wing
PVHmpv

paraventricular hypothalamic nucleus descending division medial parvicellular part
ventral zone

PVHpml

paraventricular hypothalamic nucleus magnocellular division posterior
magnocellular part lateral zone

PVHpmm paraventricular hypothalamic nucleus magnocellular division posterior
magnocellular part medial zone
PVHpv

paraventricular hypothalamic nucleus parvicellular division periventricular part

PVi

periventricular hypothalamic nucleus anterior part intermediate zone

PVpo

periventricular hypothalamic nucleus anterior part preoptic zone

RCH

lateral hypothalamic area anterior group retrochiasmatic area

SBPV

subparaventricular zone

SOp

supraoptic nucleus principal part

SOr

supraoptic nucleus retrochiasmatic part

TUi

lateral hypothalamic area middle group lateral tier tuberal nucleus intermediate part

TUl

lateral hypothalamic area middle group lateral tier tuberal nucleus lateral part

TUsv

lateral hypothalamic area middle group lateral tier tuberal nucleus subventromedial
part

TUte

lateral hypothalamic area middle group lateral tier tuberal nucleus terete part

VMH

ventromedial hypothalamic nucleus

VMHa

ventromedial hypothalamic nucleus anterior part

VMHc

ventromedial hypothalamic nucleus central part

VMHdm

ventromedial hypothalamic nucleus dorsomedial part
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VMHvl

ventromedial hypothalamic nucleus ventrolateral part

ZI

zona incerta

ZIda

zona incerta dopaminergic group
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